Science Researcher Update: Spotlight on Meetings, Conferences, and Events
Tags: November, New York, Biology, Cold Spring Harbor, Life Sciences, Conference, Genetics, Biotechnology, NY, Plant Biology, 2017, Current Science Meetings and Events, Plant and Animal Genomes, November 2017
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Advances in Prenatal Molecular Diagnostics 2017 to be held on 11/28/17 - 11/29/17.
Cell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term challenge is determining where the field heads once both options are viable. This meeting will discuss updated comparisons and examine the implementation, insurance, and clinical challenges associated with each test.
Furthermore, with advances in DNA amplification and sequencing comes greater opportunity to garner more information. Much discussion needs to take place in regards to the role of preconception counseling, expanded carrier screening, whole genome versus whole exome sequencing, and the effect these and any prenatal testing may have on the decision to continue a pregnancy or perform fetal therapy.
Tags: November, molecular biology imaging, Molecular Biology, Life Sciences, Conference, Genetics, 2017, Current Science Meetings and Events, November 2017
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Pharmaceutical Microbiology East Coast 2017 to be held on 11/13/17 - 11/14/17.
The demand for rapid microbiology in the pharmaceutical industry is at an all-time high, with regulatory bodies expressing their concern about product safety, and the microbiology market constantly growing.
This continuous expanding of the market brings many new challenges, which need to be addressed to ensure prevention of contamination and other safety issues.
SMi’s Pharmaceutical Microbiology East Coast conference will not only discuss the challenges facing the microbiology field regarding the topic of contamination control and cleanrooms, but also take a closer look at strategies for rapid microbial sterility testing, the importance of environmental monitoring to prevent potential risks, bacterial endotoxin testing, quality control and new technologies, as well as regulatory issues and updates, such as the new draft of the annex 1.
The 2017 East Coast programme will feature industry relevant presentations and case studies, and an all-new senior professional speaker line-up. Join us this November to expand your knowledge in the microbiology field at this unmissable networking conference!
Tags: November, Microbiology, East Coast, New Jersey, Life Sciences, Conference, 2017, Current Science Meetings and Events, November 2017, Iselin
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Keystone Symposia: Rigor in Science - The Challenge of Reproducibility in Biomedical Research to be held on 11/08/17.
Every researcher has a story about a compelling result that didn’t reproduce. Sometimes this is due to technical challenges or the experimental approach. However, there are also biological mechanisms that contribute to irreproducible results, and their importance is increasingly recognized by researchers, drug developers, funding agencies, and the general public.
In this discussion, we consider the issue of data reproducibility in preclinical research through a biological lens, focusing on often-neglected variables such as sex, age, microbiome, and circadian rhythms. The roundtable brings together stakeholders from across the biomedical enterprise to explore practical ways of controlling for these variables to maximize the translational potential of preclinical research. The participants include investigators Michael Holtzman, Dana Philpott, and Jeffrey Haspel, who encounter these variables in their research; Patricia Valdez, representing the NIH Extramural Research Integrity Office; and NPR Science Correspondent Richard Harris, who moderates the discussion and brings a lay perspective.
The goal of the discussion is to explore both the tensions and opportunities for exciting science that irreproducible results create in preclinical research. It also considers economical ways for researchers to address biological drivers of irreproducible results, to comply with new standards set out by funding agencies, and to enhance the potential of their work to lead to novel therapies.
Tags: November, Molecular Cell Biology, Molecular Biology, Life Sciences, Conference, 2017, Current Science Meetings and Events, November 2017
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Mayo Clinic Sleep and Stroke 2017 to be held on 11/04/17.
Sleep and Stroke 2017 will bring national and international experts in the field together to explore state-of-the-art patient care management in the diagnosis and treatment of cerebrovascular disease and sleep disorders. The latest clinical research and expert opinion will converge to improve clinical practice through a mix of session types: research presentations, poster sessions and roundtable discussions. Discussions will focus on providing research updates and evidence-based clinical strategies which sleep clinicians and neurologists can use in their daily practice.
Tags: November, Minnesota, Rochester, Mayo Clinic, Medicine, 1 day only, Life Sciences, Conference, MN, Sleep, stroke, 2017, Current Science Meetings and Events, November 2017, Rochester, Minnesota, Health
Spotlight on Science Meetings, Conferences and Events brings you information on the following: 5th Microbiome R&D and Business Collaboration Forum to be held on 11/02/17 - 11/03/17.
As part of its worldwide microbiome series, Global Engage is pleased to announce the 5th Microbiome R&D and Business Collaboration Forum: USA which will be held on 2- 3 November 2017 and will be located with the 2nd Probiotics Congress.
Last year’s congress attracted over 350 industry, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations.
Over 400 attendees are expected to converge on San Diego this fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotechs and start-ups worthy of investment, and utilise over seven hours of dedicated networking time to broaden business connections within the field. The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed.
Tags: November, microbiome, Medicine, Life Sciences, Conference, 2017, Current Science Meetings and Events, November 2017, Biotherapeutics, Health
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Stanford-EMBL: Personalized Health Conference to be held on 11/01/17 - 11/04/17.
- the molecular basis for health and disease,
- experimental models in which biomolecular systems-type approaches are developed and validated before bringing these approaches to humans, and
- clinical and ethical issues that must be considered in order to bring new approaches into the public health and clinical arenas.
Tags: November, Medicine, Life Sciences, Conference, 2017, Current Science Meetings and Events, November 2017, Health
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Genomic Informatics to be held on 11/01/17 - 10/04/17.
The next Cold Spring Harbor Laboratory conference on Genome Informatics will be held at Cold Spring Harbor, New York (this meeting has alternated with the Hinxton meeting started under the joint auspices of CSHL and the Wellcome Trust). The meeting will begin at 7:30 p.m. on Wednesday, November 1, and finish with lunch on Saturday, November 4, 2017.
- Personal and Medical Genomics
- Transcriptomics, Alternative Splicing and Gene Predictions
- Epigenomics and Non-Coding Genome
- Data Curation and Visualization
- Variant Discovery and Genome Assembly
- Comparative, Evolutionary, and Metagenomics
Tags: November, Bioinformatics, Massachusetts, Woods Hole, Cold Spring Harbor, Conference, Genomics, laboratory, 2017, Current Science Meetings and Events, November 2017
Spotlight on Science Meetings, Conferences and Events brings you information on the following:Precision: Blood Cancer summit
Over the two days, this exclusive summit will bring together will bring together senior scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.The summit will cover the latest updates from the pipelines of small and large drug developers, and feature discussions around the latest trends in precision medicine through case studies from early discovery to development. Topics Include: Immunotherapy / CAR-TCR, Biomarkers /CDx, Novel approaches (Including Antibody Drug Conjugates)
Tags: November, California, Biomarkers, San Francisco, Life Sciences, 2017, Current Science Meetings and Events, November 2017, Cancer Immunotherapy, Blood Cancer, Antibody Drug Conjugates
Spotlight on Science Meetings, Conferences and Events brings you information on the following: Understanding Data Integrity
The Anti-Fibrotic Drug Development Summit is the first meeting to assemble researchers and program leaders from cross-industry to share experiences and insights on how to better directly target the drivers of fibrotic diseases.
Developed in combination with experts from GSK, BMS, Pfizer and many more this forum aims to better elucidate how the underlying fibrotic biology can be more effectively drugged, to discern which models of fibrosis are the most robust and how biomarkers can be implemented into improved clinical trials designs.
Tags: November, Massachusetts, Boston, Life Sciences, Life Science, 2017, Current Science Meetings and Events, November 2017, Anti-Fibrotic Drug Development, Fibrotic Diseases